Maravai LifeSciences
Supplies nucleic-acid tools and biologics testing products for therapies, vaccines, diagnostics, and research.
$7.79
After-hours close+0.13 (+1.74%)
At close$7.66(−8.54%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.06 | — | — |
| Aug 2026 | −$0.04 | −$0.02 | +54.1% |
| May 2026 | −$0.05 | $0.01 | +120.0% |
| Feb 2026 | −$0.07 | −$0.04 | +42.9% |
| Nov 2025 | −$0.06 | −$0.08 | −33.3% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Sep 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.06 | — | — | $43.6M | — | — |
| Aug 6, 2026 | −$0.04 | −$0.02 | +54.1% | $48.7M | $51.4M | +5.7% |
| May 7, 2026 | −$0.05 | $0.01 | +120.0% | $53.0M | $65.8M | +24.2% |
| Feb 25, 2026 | −$0.07 | −$0.04 | +42.9% | $49.0M | $49.9M | +1.7% |
| Nov 6, 2025 | −$0.06 | −$0.08 | −33.3% | $49.1M | $41.6M | −15.1% |
The latest year is open to everyone — the 23 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 18, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 22, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 23, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 10, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 2, 2021 | ||||||
| Nov 23, 2020 | ||||||
| Sep 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||